Abstract
Increased activities of the renin system and the sympathetic nervous system are key contributors to the pathogenesis of hypertension in chronic kidney disease patients. Eprosartan is an angiotensin II receptor antagonist, which effectively reduces muscle sympathetic nerve activity (MSNA) in chronic kidney disease patients.
| Original language | English |
|---|---|
| Pages (from-to) | 15-17 |
| Number of pages | 3 |
| Journal | Journal of clinical and basic cardiology |
| Volume | 8 |
| Issue number | 1-4 |
| Publication status | Published - 1 Dec 2005 |
Keywords
- Angiotensin II antagonist
- Angiotensin II receptor blocker
- Chronic kidney disease
- Hypertension
- Sympathetic nervous system